Market Access
pharmaphorum podcast episode 115

The 2024 biopharma M&A landscape: An overview

It’s been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats.

Sales & Marketing

Digital

Market Access

Market Access
Data representation of Europe

European biopharma at a crossroads

If Europe can bridge its operational gaps while leveraging its scientific base, it can carve out a distinctive and sustainable leadership position.

Newsletters and Deep Dive
digital magazine

Oncology

Patients

R&D